Revvity Inc (RVTY)

Dec 26, 2025

Can Revvity Inc. stock deliver strong annual returnsPortfolio Risk Assessment & Rapid Portfolio Trading - bollywoodhelpline.com

Dec 26, 2025

Dec 24, 2025

Revvity Earnings Notes - Trefis

Dec 24, 2025

Dec 24, 2025

Revvity advances AI-driven scientific discovery with Signals Xynthetica - MSN

Dec 24, 2025

Dec 22, 2025

Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Dec 22, 2025

Dec 22, 2025

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 22, 2025

Dec 22, 2025

(RVTY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Dec 22, 2025

Dec 22, 2025

Did Revvity’s New AI Discovery Platform (RVTY) Quietly Redefine Its Innovation Moat? - simplywall.st

Dec 22, 2025

Dec 22, 2025

Revvity introduces AI-augmented design platform for molecular and materials discovery - BioSpectrum India

Dec 22, 2025

Dec 20, 2025

Aug Patterns: How Revvity Inc stock reacts to global recession fearsJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn

Dec 20, 2025

Dec 19, 2025

Is Revvity Inc. stock a defensive play in 2025Global Markets & Stepwise Trade Signal Implementation - Улправда

Dec 19, 2025

Dec 19, 2025

How cyclical is Revvity Inc. stock compared to rivalsJuly 2025 Price Swings & Comprehensive Market Scan Reports - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica - TradingView — Track All Markets

Dec 19, 2025

Dec 19, 2025

Will Revvity Inc. stock reach all time highs in 2025Weekly Trade Report & Expert Verified Stock Movement Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Raymond James reiterates Outperform rating on Revvity stock after site visit - Investing.com Nigeria

Dec 19, 2025

Dec 19, 2025

Raymond James reiterates Outperform rating on Revvity stock after site visit By Investing.com - Investing.com India

Dec 19, 2025

Dec 19, 2025

What consensus target says about Revvity Inc. stockRate Cut & AI Optimized Trade Strategies - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Revvity Inc. stock could outperform in 2025Weekly Profit Analysis & Precise Buy Zone Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Revvity Inc. stock benefit from automationJuly 2025 Closing Moves & Technical Buy Zone Confirmations - Улправда

Dec 19, 2025

Dec 18, 2025

Is Revvity Inc. stock a buy on dipsWeekly Trading Summary & Daily Price Action Insights - Улправда

Dec 18, 2025

Dec 18, 2025

What analyst consensus says on Revvity Inc. stockInsider Selling & Proven Capital Preservation Tips - Улправда

Dec 18, 2025

Dec 18, 2025

Revvity (BSP:R1VT34) EV-to-OCF : 22.14 (As of Dec. 18, 2025) - GuruFocus

Dec 18, 2025

Dec 18, 2025

Will Revvity Inc. stock see PE expansionMarket Activity Summary & High Conviction Buy Zone Picks - ulpravda.ru

Dec 18, 2025

Dec 18, 2025

Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire

Dec 18, 2025

Dec 18, 2025

Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - simplywall.st

Dec 18, 2025

Dec 18, 2025

How is Revvity's stock performance compared to other health care stocks? - MSN

Dec 18, 2025

Dec 17, 2025

Revvity (NYSE: RVTY) officer disposes 25 shares for RSU tax withholding - Stock Titan

Dec 17, 2025

Dec 17, 2025

3 Reasons RVTY is Risky and 1 Stock to Buy Instead - The Globe and Mail

Dec 17, 2025

Dec 17, 2025

Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design - Indian Pharma Post

Dec 17, 2025

Dec 16, 2025

Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 16, 2025

Dec 16, 2025

Revvity to launch AI models-as-a-service for scientific discovery - Investing.com Nigeria

Dec 16, 2025

Dec 16, 2025

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials D - PharmiWeb.com

Dec 16, 2025

Dec 16, 2025

Revvity Introduces New AI Service for Molecular, Materials Design - marketscreener.com

Dec 16, 2025

Dec 16, 2025

Revvity, Inc. Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - marketscreener.com

Dec 16, 2025

Dec 16, 2025

Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq

Dec 16, 2025

Dec 16, 2025

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - Yahoo Finance

Dec 16, 2025

Dec 15, 2025

Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch

Dec 15, 2025

Dec 15, 2025

Revvity Shares Fall After BofA Downgrade - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Revvity stock rating downgraded to Neutral by BofA Securities - Investing.com South Africa

Dec 15, 2025

Dec 15, 2025

Revvity (NYSE:RVTY) Lowered to "Neutral" Rating by Bank of America - MarketBeat

Dec 15, 2025

Dec 15, 2025

Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Overweight Rating - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Wells Fargo Adjusts Price Target on Revvity to $107 From $102, Maintains Equalweight Rating - marketscreener.com

Dec 15, 2025

Dec 15, 2025

BofA Securities Downgrades Revvity to Neutral From Buy - marketscreener.com

Dec 15, 2025

Dec 15, 2025

How Is Revvity's Stock Performance Compared to Other Health Care Stocks? - Barchart.com

Dec 15, 2025

Dec 13, 2025

EdgePoint Investment Group Inc. Boosts Stock Position in Revvity Inc. $RVTY - MarketBeat

Dec 13, 2025

Dec 12, 2025

Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch

Dec 12, 2025

Dec 10, 2025

Federated Hermes Inc. Cuts Position in Revvity Inc. $RVTY - MarketBeat

Dec 10, 2025

Dec 10, 2025

The Goldman Sachs Group Begins Coverage on Revvity (NYSE:RVTY) - MarketBeat

Dec 10, 2025

Dec 10, 2025

Goldman Sachs initiates coverage of Revvity (RVTY) with neutral recommendation - MSN

Dec 10, 2025